BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts

 BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts

PR Newswire

FRANKLIN LAKES, N.J., Nov. 6, 2012

FRANKLIN LAKES, N.J., Nov. 6, 2012 /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX), a leading global medical technology company, announced
today that it is pledging up to $500,000, including $250,000 in cash and up to
$250,000 in product donations, to support Hurricane Sandy relief efforts. BD's
cash commitment will be shared among the American Red Cross, the United Way,
and several other nongovernmental humanitarian relief organizations with which
BD regularly partners. In addition, BD will match donations made by BD
employees to the American Red Cross, up to a total of $50,000.

BD's product donations to AmeriCares, Heart to Heart International and Direct
Relief International will support their hurricane response efforts, and the
Company will continue to assess needs and seek additional opportunities to
provide support. Products supplied to these organizations include syringes,
insulin syringes, BD Sharps containers, alcohol swabs, lancets and BD
Vacutainer^® tubes.

"BD is committed to working with our trusted partners to support critical
relief efforts following this historic storm that so severely impacted the
east coast, including our home state of New Jersey," said Vincent A. Forlenza,
Chairman of the Board, Chief Executive Officer and President.

About BD
BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents. The Company is
dedicated to improving people's health throughout the world. BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines. BD's capabilities are instrumental in
combating many of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000
associates in more than 50 countries throughout the world. The Company serves
healthcare institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public. For more information, please
visit www.bd.com.

Contacts:
Colleen T. White, Corporate Communications – 201-847-5369;
colleen_white@bd.com
Monique N. Dolecki, Investor Relations – 201-847-5378;
monique_dolecki@bd.com

SOURCE BD (Becton, Dickinson and Company)

Website: http://www.bd.com
 
Press spacebar to pause and continue. Press esc to stop.